Analysis GeneDx (GENEDX) is poised for a critical Q3, with market participants keenly awaiting its testing growth...
Uncategorized
Analysis AstraZeneca (AZN) has received a ‘buy’ rating from Jefferies, projecting an ambitious $80 billion sales target...
Analysis November could witness a stock market rebound for year-to-date losers, driven by tax-loss harvesting strategies. This...
Analysis Wipro ADR/GDR analysis for 2025 provides a crucial outlook for investors tracking the IT giant’s future....
Analysis IndiGo stock has secured a ‘Buy’ rating with an ambitious ₹7,000 target price for 2025, underpinned...
Results Tata Investment Corporation reported a robust 19.3% year-on-year surge in consolidated net profit to ₹148 crore...
Analysis SPYG ETF’s performance as of October 25, 2025, presents a mixed picture for the S&P 500...
Analysis Chugai Pharmaceutical’s Q3 2025 results have defied typical market reactions, showing an EPS beat yet a...
Analysis As autumn approaches, investors are exploring value beyond traditional markets, with seasonal getaways to historic towns...
Market Update Federal Bank shares surged over 2.95% to ₹233.70 on Monday, reaching a fresh 52-week high...
